Search - tctmd.com

Displaying 21 - 40 of 55

Sort: Relevancy | Date

News Daily News

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

Caitlin E. Cox

June 17, 2025

News Daily News

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

L.A. McKeown

June 17, 2025

News Daily News

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Michael O'Riordan

June 13, 2025

News Daily News

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

Michael O'Riordan

June 10, 2025

News Daily News

Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry

Caitlin E. Cox

June 09, 2025

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

L.A. McKeown

May 22, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Conference News European Congress on Obesity 2025

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

Michael O'Riordan

May 14, 2025

News Daily News

Procedural Volumes Matter for VT Ablation

Todd Neale

May 12, 2025

News Conference News SCAI 2025

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

L.A. McKeown

May 09, 2025

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

News Conference News CX Symposium 2025

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

L.A. McKeown

April 30, 2025

News Daily News

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Yael L. Maxwell

April 29, 2025

News Conference News HRS 2025

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

Todd Neale

April 28, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

Yael L. Maxwell

April 16, 2025

News Conference News ACC 2025

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

Michael O'Riordan

April 01, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

Presentation ACC 2025

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Presenter: Darren K. McGuire

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

Advertisement

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

Majority of US Adults Have High Long-term Risk of CVD: NHANES

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

Procedural Volumes Matter for VT Ablation

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

What’s Going to Be Hot at ACC 2025?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content